NSE
Beta Drugs LimitedBETA
Beta Drugs Limited is an NSE-listed company (BETA).
AI-generated overview — verify before relying on it.
Net institutional flow
+₹26.3 Cr
Institutional buyers
1 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | BETAThis | +₹26.3 Cr | 2 | — | — | — | — |
| 3 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 4 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — BETA day by day
- 2026-06-15FilingSignificant increase in volume has been observed in Beta Drugs Limited. The Exchange, in order to ensure that Order Win
- 2026-06-12FilingSignificant increase in volume has been observed in Beta Drugs Limited. The Exchange, in order to ensure that Order Win
- 2025-11-13BulkBUY · ₹26.3 CrAIRAVAT CAPITAL TRUST II
- 2025-11-13BulkSELL · ₹31.2 CrNEERAJ BATRA
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 3
- 3
2 deals · 2025-11-13 → 2025-11-13
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-11-13 | AIRAVAT CAPITAL TRUST II | Institution | BUY | ₹26.3 Cr |
| 2025-11-13 | NEERAJ BATRA | HNI / other | SELL | ₹31.2 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
Calls & transcripts
- Significant increase in volume has been observed in Beta Drugs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Beta Drugs Limited has submitted their response. (PDF) →
- Significant increase in volume has been observed in Beta Drugs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. (PDF) →
News & chatter on BETA
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.